Real world study of Advanced Prostate Cancer patients in India
Not Applicable
- Conditions
- Health Condition 1: N428- Other specified disorders of prostate
- Registration Number
- CTRI/2024/06/068779
- Lead Sponsor
- Pfizer Products India Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed and/or treated with mCSPC or mCRPC 01 January 2023 onwards,
inclusive. mCSPC is defined as the current and/or historical presence of metastases
on any imaging modality sensitive to hormone therapy. mCRPC is defined as the
current and/or historical presence of metastases on any imaging modality with
evidence of disease progression (a rising PSA or radiographic progression (as defined
by the investigator) despite ongoing castration therapy [ADT or prior surgical
orchiectomy]).1,9
Aged at least 18 years upon diagnosis of mCSPC or mCRPC.
Exclusion Criteria
Previously enrolled in an interventional trial related to metastatic prostate cancer.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method